Yunnan Baiyao Group Co.,Ltd
000538
株式のランク
#1530
Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd.... Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd. specializes in the pharmaceutical industry. Its diverse portfolio encompasses health supplements, a wide array of medications, medical devices, traditional Chinese medicine ingredients, and even tea. These offerings are marketed under various brand identities, including Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong. The company, established in 1902, maintains its principal offices in Kunming, China.
株価
$7.90
最終同期: 2026-10-22
時価総額
$14.09B
変化（1日）
-0.13%
変化（1年）
-0.53%
国
CN
取引 Yunnan Baiyao Group Co.,Ltd (000538)
カテゴリー
Healthcare
Yunnan Baiyao Group Co.,Ltd（000538）の利益
Jun 2026 時点の利益 TTM: $912.54M
Yunnan Baiyao Group Co.,Ltd の最新の財務報告によると、同社の現在の利益は $912.54M です。2024 年には $778.82M の利益を上げ、これは 2023 年の利益 $680.64M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Yunnan Baiyao Group Co.,Ltd の利益の推移（2001 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $912.54M | 5.65% |
| 2025 | $863.77M | 10.91% |
| 2024 | $778.82M | 14.42% |
| 2023 | $680.64M | 39.03% |
| 2022 | $489.57M | -10.63% |
| 2021 | $547.78M | -47.38% |
| 2020 | $1.04B | 53.39% |
| 2019 | $678.73M | 26.29% |
| 2018 | $537.42M | -3.46% |
| 2017 | $556.68M | 13.76% |
| 2016 | $489.35M | -1.17% |
| 2015 | $495.14M | 5.39% |
| 2014 | $469.84M | 5.50% |
| 2013 | $445.34M | 51.72% |
| 2012 | $293.52M | 31.52% |
| 2011 | $223.18M | 41.68% |
| 2010 | $157.52M | 52.41% |
| 2009 | $103.36M | 27.02% |
| 2008 | $81.37M | 49.60% |
| 2007 | $54.39M | 27.75% |
| 2006 | $42.58M | 23.87% |
| 2005 | $34.37M | 33.96% |
| 2004 | $25.66M | 60.46% |
| 2003 | $15.99M | 11.97% |
| 2002 | $14.28M | 44.62% |
| 2001 | $9.88M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $3.62B | 296.46% |
DE
|
|
| $3.40B | 273.13% |
DE
|
|
| $1.72B | 88.88% |
JP
|
|
| $930.30M | 1.95% |
CH
|
|
| $1.69B | 85.49% |
IN
|
